Marketresearchnews

Tuesday, 18 May 2021

CPAP Devices Market – Insights on Upcoming Trends 2027

Continuous positive airway pressure (CPAP) devices are used in the treatment of choice for obstructive sleep apnea syndrome. CPAP works by blowing air into the nose and throat. The blow causes a positive pressure to hold the upper airway open during sleep and thus helps in the treatment of snoring. This device typically used when the patient has a breathing problem. Additionally, it increases the air pressure in the throat to avoid airway from collapsing when breathing. It can be used every night at home while sleeping. The global CPAP market is majorly driven by increasing number of patients with sleep apnea, obesity, and other respiratory diseases. According to the World Health Organization (WHO), in 2016, more than 1.9 billion adults, above 18 years were overweight. Out of these over 650 million were obese. The report also suggests that over 340 million children and adolescents aged 5-19 were overweight or obese in 2016. Thus, rising number of patient with obesity generating the exponential demand for CPAP devices market.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/939

According to the WHO, in 2016, around 39% of 41 million children under the age of 5 were overweight or obese. Advances in technology such as improved mask design, oral appliances, use of oxygen devices, rising healthcare expenditure, and increasing demand for the devices have fuelled the market growth. However, CPAP is not always effective since some patients find it uncomfortable and sometimes it shows adverse effects. The high cost of the devices and their adverse effect may slow the market growth.

Global continuous positive airway pressure (CPAP) devices market is expected to grow at a CAGR of 7.1% during the forecast period 2017-2027.

Segmentations

Global continuous positive airway pressure (CPAP) devices market is segmented on the basis of product type, features, automation, and end user

On the basis of the product type, it is segmented into CPAP motors, CPAP hoses, CPAP mask, and others.

On the basis of the features, it is segmented into the humidifier, portability, heated tubing, and others.

On the basis of the automation, it is segmented into manual and automatic.

On the basis of the end user, it is segmented into hospitals, private clinics, home care, and others.

Regional Analysis

The Americas hold the largest share of the global market owing to increasing incidence of obesity, unhealthy diet, and physical inactivity. According to the updated report by the Centers for Disease Control and Prevention (CDC) in 2017, a total number of adults diagnosed with chronic bronchitis in the past year was 9.3 million. The report further adds that around 3.8% of the total adult population in the U.S. diagnosed with chronic bronchitis, in 2016. Presence of well-developed technology, high health care spending, increased R&D activities, and the concentration of major companies have fuelled the growth of the market in this region.

Europe holds the second position followed by the Asia Pacific in the global CPAP devices market owing to the rising patient population diagnosed with respiratory diseases. Furthermore, the government support for research & development and availability of funds for research are likely to fuel the CPAP devices market growth over the forecast period.

Asia Pacific is the fastest growing CPAP devices market owing to unhealthy diet and associated lifestyle changes. Moreover, the increased presence of rapidly developing healthcare technology, high healthcare expenditure, R&D activities, and the concentration of major companies are fuelling the growth of the market in this region. Increasing demand for new treatment methods in countries like India and South Korea is likely to emerge as the fastest growing market across the globe.

On the other hand, the Middle East and Africa account for the lowest share of the global market owing to lack of technical knowledge and poor medical facilities.

Key Players

Some of key the players in the market are Medtronic (U.S.), Koninklijke Philips N.V. (the Netherlands), 3B Medical, Inc. (U.S.), Armstrong Medical Inc. (U.S.), ResMed (U.S.), Smiths Medical (U.S.), Apex Medical Corp. (Taiwan), Fisher & Phillips LLP (U.S.), Cardinal Health (U.S.) Beijing Dehaier Medical Technology Co., Ltd. (China), DeVilbiss Healthcare LLC (US), and Invacare Corporation (US).

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/continuous-positive-airway-pressure-devices-market-939

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Human Insulin Market to Witness Widespread Expansion During 2020-2027

Global Human Insulin Market is expected to grow at CAGR of 12.10% to reach USD 90,812.40 Million till 2025. Human insulin in the report refers to synthetic insulin manufactured in laboratories by increasing insulin protein with the help of e. coli bacteria. Human insulin can be administered orally or through insulin infusion devices. Some conventional insulin infusion devices are syringes, injection pens, and insulin pumps. These devices are used to deliver insulin on time and regularly.

Increasing prevalence of diabetes, rising obesity endemic, rise in geriatric population, and increasing awareness among people about diabetic care and technological advancement in delivery devices of insulin are some of the factors influencing the growth of the human insulin market. However, strict regulatory requirements for approval of insulin and high cost of insulin analog inhibit the growth of the human insulin market.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/951

Market Dynamics

The increasing affordability of human insulin is one of the key factors driving the human insulin market. In May 2019, Eli Lilly and Company launched Insulin Lispro Injection for people who use Lilly's rapid-acting insulin and need a lower-cost option. Insulin Lispro Injection has a 50% lower price than its identical medicine, Humalog U-100 (insulin lispro injection).

Increasing diabetic population is also strongly impacting the growth of the market. Diabetes is a chronic and non-communicable disease, and its global prevalence is rising enormously. Nowadays, it is one of the leading causes of death and has an increased risk of developing several serious health problems. It is the primary cause of cardiovascular diseases, kidney diseases, eye disorders, and strokes.

As per 2017, National Diabetes Statistic Report suggested by the Centers for Disease Control and Prevention, more than 100 million people in the US have diabetes or prediabetes.

Segmentation

Based on type, the global human insulin market has been segmented into traditional human insulin and modern human insulin. Traditional human insulin segment includes premixed traditional, intermediate-acting, and short-acting. Modern human insulin segment includes premixed modern, long-acting, and rapid-acting. Modern human insulin was the leading segment in 2018. Modern human insulin, also known as analog insulin, is prescribed by physicians for the treatment of diabetes. It is the customized form of traditional human insulin and provides effective results in comparison to traditional human insulin.

The global human insulin market, by brand, has been segmented into Lantus, Novorapid, Humalog, Novomix, Levemir, Apidar, Humulin, and Insuman. Lantus is a long-acting human insulin analog, and it is available in more than 120 countries. Among all the brands, Lantus commands the largest share in the human insulin market. Apidra is a rapid acting human insulin analog. Also, Apidra and Levemir are the fastest growing brand in the human insulin market. Moreover, there are various drugs in the pipeline, which would have a positive impact on the growth of the market in the coming years.

Regional Analysis

The global human insulin market has been categorized as the Americas, Europe, Asia-Pacific, and Middle East & Africa.

The Americas dominate the global human insulin market, owing to the growing old age population, increasing healthcare awareness, rising prevalence of diabetes, improvement in reimbursement policies, and increasing clinical trials driving the growth of human insulin.

The European Human Insulin market has been segmented into Western Europe and Eastern Europe. In 2018, Europe stood second in the global Human Insulin market. Increasing focus on the treatment of diabetes and rising clinical trials by market players will support the growth of Europe Human Insulin market. For instance, a France-based firm, Adocia received positive topline pharmacodynamic and safety results from the first Phase 1 study of ADO09. ADO09 is intended to improve postprandial glucose control and long-term outcomes for people requiring prandial insulin treatment.

Asia-Pacific is expected to register the highest CAGR during the forecast period. Companies are introducing new advanced products in this region, which is boosting Asia-Pacific human insulin market. In March 2018, Biocon Ltd and Mylan NV received approval for biosimilar insulin glargine Semglee 100 IU/mL 3 mL prefilled pen from the Therapeutic Goods Administration (TGA) Australia.

On the other hand, the Middle East & Africa holds the least share in the global human insulin market due to the low economic development, especially within the African region.

Key Players

The prominent players in the global human insulin market are ADOCIA, MERCK & CO., INC., Julphar, Pfizer Inc., Bristol-Myers Squibb Company, GLAXOSMITHKLINE PLC, SANOFI, Oramed, Novo Nordisk India Pvt. Ltd, Eli Lilly and Company, BIOCON, and Tonghua Dongbao Pharmaceutical Co., Ltd.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/human-insulin-market-951

About US:

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Maternal health Market to Witness Widespread Expansion During 2020-2027

Market Scenario

Every year the death of women is high because of the pregnancy complications. The number is much reduced in the todays date. The reason behind this is government initiatives, the government is trying to help pregnant women for their better health of mother and baby. The best example of the initiatives can be seen by UNICEF (India). The program they have started is Janani Shishu Suraksha Karyakaram (JSSK) scheme which provides free maternity service across India. The services are provided to increase number of emergency referral systems and maternal death audits, and improvements by government and management for health services. Every year near about 800 women die in the world. India contributes 20% in this number of 800. The number of deaths are being controlled by the WHO, CDC and UNICEF programs. The education is given to women and the health services are provided at large to women. Adolescent women are at risk of the complications during pregnancy, these women are provided with health services. The post pregnancy services are also provided to them.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/732

The maternal health market will grow at a rate of 7% CAGR during the forecasted period 2017-2023. The deaths was found reduced in 2012 it was near approximately 175. This will be further reduced in coming years with the help of scheme like JSSK by UNICEF in India.

Study objectives:

To provide detail analysis of the market structure along with estimated future growth forecast for the next 7years about various segments and sub-segments of the global maternal health market.
To provide insights about factors affecting the market growth.
To analyze the global maternal health market based on various factors - price analysis, supply chain analysis, Porters Five Force Analysis etc.
To provide past and estimated future revenue of the market’s segments and sub-segments with respect to four main geographies and their countries - Americas, Europe, Asia-Pacific along with Middle East & Africa.
To provide country level analysis of the market with respect to the current market size and future growth prospect.
To provide country level analysis of the market’s segments which includes by type of pregnancy, by risk in pregnancy, by complications, by delivery type.
To provide overview of key players and their strategic profiling in the market, comprehensively analyzing their core competencies and drawing a competitive landscape of the market.
To track and analyze developments which are competitive in nature such as joint ventures, strategic alliances, mergers and acquisitions, new product developments along with research and developments currently taking place in the global maternal health market.

Segments:

The market of the maternal health is segmented into type of the pregnancy, risk in pregnancy and complications. Types of pregnancy includes Intrauterine, Ectopic, Tubal and Others. On the basis of risk occurred in pregnancy which have high risk and molar risk. On the basis of the complications like miscarriage, premature labor and birth, preeclampsia, gestational diabetes, placenta previa and others. The miscarriage further have sub segments like threatened, inevitable, complete, and incomplete.

Regional analysis:

Globally the deaths of women are increasing due to the complications during pregnancy. The market for the maternal health is divided into four main geographic regions. The main regions are Americas, Europe, Asia-Pacific and Middle East and Africa. Further the regions are divided into developed and developing countries falling under this regions. The deaths of women have increased in Americas despite of advanced medicine and technology over past 25years. The reason behind this is of heart conditions, blood pressure, bleeding and many more complications.
Intended Audience

Government hospitals
Private hospitals
NGOs
Medical Organizations and Institutes
Pharmaceutical Companies

Key players of Global Maternal Health Market:

Some of the global and local players are engaged in the maternal health those are, Agile Therapeutics (USA), Fuji Latex Co (Japan), Okamoto industries, Reckitt Benckiser Group Plc.(UK), Sanofi (India), Johnson and Johnson(USA).
The report for Global Maternal Health Market by Market Research Future comprises of extensive primary research along with the detail analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain a deeper insight of the market and industry performance. The report gives a clear picture of current market scenario which includes past and estimated future market size with respect to value and volume, technological advancement, macro economical and governing factors in the market. The report provides detail information about and strategies used by top key players in the industry. The report also gives a broad study of the different market segments and regions.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/maternal-health-market-732

About US:

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Soaring Demand Drives Global Microfluidics Device Market Growth During the Forecast Period, 2020-2027

Microfluidic devises Market overview

According to the latest report, the global Microfluidic Devices market size is predicted to reach USD 14,296.04 Million by the end of the year 2025 with a significant growth rate of CAGR of 19.70%. A Microfluidic device utilizes the chemical and physical properties of gases and liquids at a micro-scale. This device provides various benefits over evenly sized systems. Microfluidics investigates and uses fewer samples volume, chemicals, and also decreases global fees of applications.

The microfluidic device is an advanced technology that helps integrate several medical tests on a single chip. It is an important technology for miniaturization, integration, industrialization, and parallelization of several tests in different fields of biological research, in developments of drugs, and diagnosis. The rise in demand for the microfluidic technologies for miniaturization of the chip and testing products are the major driving factors for the growth of the Microfluidic Devices market. The increasing demand for genomics and proteomics are some other major driving factors. Moreover, the rigid policies of the government may hamper the growth of the global Microfluidic Devices market.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/684

This report contains all the information on the global Microfluidic Devices market research and the market strengths. The report also contains the culmination of dynamics, segmentation, key players, regional analysis, and other important factors. And a detailed analysis of the global Microfluidic Devices market and forecast to 2025 is also included in the report.

Covid 19 Analysis

The outbreak of the global pandemic covid 19 has affected the global Microfluidic Devices market, by creating a burden on the laboratories due to the large numbers of cases that were supposed to be tested in the labs. Hence, there is some positive impact as well; Microfluidic is basically handling of a small number of fields in chambers and microscale channels. It helps the researchers to manage fewer amounts of samples and generates faster results as compared to the conventional methods, just because of the high potentials in advanced microfluidic technology. This technology is considered the promising technology in this global pandemic situation of covid 19.

Market Dynamic

Drivers

The advancement in the technology of diagnosis devices is the major factor propelling the growth of the global Microfluidic Devices market. Along with that, the rising incidence of chronic diseases and accordingly increased demand for Microfluidic technology has further boosted the demand for the global Microfluidic Devices market.

Opportunities

The current scenario of the market is witnessing major advancement in technology, as the developments in Microfluidic are leading towards the cost-effective mass production process of diagnostic devices. it is also creating various opportunities for the major key manufacturers in the market as well by pairing smartphones to Microfluidic which enables the deployment of point-of-care testing. The application of Microfluidic devices is likely to boost the demand for the Microfluidic devices market in the future.

Restraints

The lack of skilled technicians in the Microfluidic along with the issues related to the regulatory environment is the major restraint of the global Microfluidic market. The high cost of Microfluidics types of equipment is another major restraint especially in the developing countries as it is unaffordable due to the emerging low income of such countries.

Challenges

The major challenges faced by the key manufacturers of Microfluidic devices are to provide results immediately outside the conventional laboratory environment which involves point-of-care device market (POCT) testing. It is strongly impacting the growth of the global Microfluidic Devices market.

Cumulative Growth Analysis

The increasing advancement in technology is the major key driving factor for the Microfluidic device market. For instance, in the month of January 2019, L’Oreal has launched a prototype of a wearable sensor from the L’Oreal Technology Incubator at the show of Consumers Electronic in 2019 and also introduced a companion app. The first wearable microfluidic sensor was introduced by My Skin Track pH by La Roche-Posay and companion app which helps to easily measure the pH balance in skin and accordingly creates some customized product regimens for better care for the skin.

Value Chain Analysis

According to the latest report the global Microfluidic devices market has been segmented onto the basis of industry, materials, application, and regions. On the basis of industry, the global Microfluidic devices market has been segmented into pharmaceutical, medical devices, in-veto diagnostics, and others. The pharmaceutical segment is further segmented into chips for lab analytics, accurate dispensing devices, and micro-reactors for drug synthesis. The in-veto segments account for the maximum shares of 50.6% in the year 2018 due to the increasing demand for early diagnosis.

On the basis of materials, the global Microfluidic devices market has been segmented into glass, polymer, silicon, and others. The polymer segments account for the maximum share in the global Microfluidic devices market due to its fast fabrication process and cheaper costs as compared to the glass and silicon. On the basis of application the global Microfluidic devices market is segmented into pharmaceutical and life science research, clinical and veterinary diagnostics, point of care diagnostics, analytical devices, drug delivery, environmental and industrial, and others.

Segmentation Overview

The market is segmented on the basis of the industry, materials, application, and regions. The global Microfluidic devices market is expected to witness decent growth during the forecast period.

By Application

Based on the application, the market is segmented into pharmaceutical and life science research, clinical and veterinary diagnostics, point of care diagnostics, analytical devices, drug delivery, environmental and industrial, and others.

By End-users

Based on the propulsion types, the market is segmented into pharmaceutical, medical devices, in-veto diagnostics, and others.

Regional Analysis

According to the latest reports, the global Microfluidic devices market has been segmented into the Americas, Europe, Asia Pacific, and the Middle East, and Africa. America accounts for the maximum share in the global Microfluidic devices market due to the rising geriatric population, increasing chronic diseases and lifestyle diseases, raising awareness in healthcare, and the developments in technologies for several applications and along with that the extensive insurance infrastructure facilities are driving the growth of the global Microfluidic Devices market.

Europe is expected to stand second in the global Microfluidic devices market due to advancements in technology and the support of the major levy players for the growth of the Microfluidic devices market. Asia Pacific is predicted to register the maximum CAGR during the forecast period due to the introduction of new advanced products in these regions. The Middle East & Africa holds the least Microfluidic devices market share due to the low development in the economy mainly in the African region.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/microfluidics-device-market-684

About US:

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Global G-Protein Coupled Receptors Market size and forecast, 2020-2027

Market Forecast

G-Protein Coupled Receptors Market trends is expected to cross USD 4,200 Million by 2025 at a CAGR of 7.1% during the forecast period.

The growing use of G-protein coupled receptors in medicate disclosure and advancement forms is set to drive the demand of G protein-coupled receptors.

G-protein coupled receptors are most commonly prescribed for the treatment of cardiovascular disease, oncology, immunology, respiratory system, central nervous system (CNS), and others. GPCRs (G-protein coupled receptors) play a physiological role in the regulation of cardiac function in both health and disease and thus represent one of the largest class of surface receptors targeted by drugs.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/8356

Market Synopsis

There is an increase in government support in R&D activities in the global G-protein coupled receptors market.

The government is supporting research & development for biosensors, orphan drug receptors, sedate targets, and high-throughput screening methods to bind the nucleotides guanosine triphosphate (GTP) and guanosine diphosphate (GDP).

Market Influencers

An increasing number of allosteric modulators, biological drugs, and biased agonists that target the receptors accelerate the demand for assays in G-protein coupled receptors market.

Market Drivers

The increasing number of drugs under clinical and preclinical studies that target these receptors. Approximately, in 2018, there were 19% of drugs under clinical trial phase 1 which targets G protein-coupled receptors
Existence of a variety of agents that stimulate GPCR activity. The drugs salmeterol and albuterol, bind and activate beta-adrenergic GPCRs, stimulate airway opening in the lungs and thus are used in the treatment of some respiratory conditions, including chronic obstructive pulmonary disease and asthma.
The growing use of G-protein coupled receptors in medicate disclosure and advancement forms.
Increasing number of allosteric modulators, biological drugs, and biased agonists that target these receptors.
Presence of a large number of approved drugs that target G-protein coupled receptors. In 2018, there were approximately 700 approved drugs that target G protein-coupled receptors (GPCRs).

Market Restraints

High cost involved in the maintenance of GPCR cell lines.
Stringent government policies

Segmentation

By Product

Cell Lines: Cell lines play a significant role in the cellular impedance assays for the detection of GPCR targets.

Detection Kits: Fastest segment as detection kits are easy to use, robust, and highly sensitive products to evaluate the activity through different pathways.

Cell Culture Reagents: Largest segment as it is one of the most conventional and affordable ways of use with effective

Ligands: Ligands stabilize G protein-coupled receptors and affect its functions. GPCR binds with many different types of ligands.

By Assay Type

Calcium Functional Assays: Fastest segment. Due to the numerous advantages associated with the use of calcium flux assays. The benefits include high sensitivity, user configurability, ease in the estimation of calcium flux.
cAMP Functional Assays: It is cyclic adenosine monophosphate (cAMP). It is an essential intracellular second messenger in GPCR.
cGMP Assays: Acyclic guanosine monophosphate (cGMP) assay provides a competitive immunoassay for sensitive and quantitative determination of cGMP level in biological samples.
GTP Gamma S Binding Assays: It can be used to differentiate agonist, antagonist, and inverse agonist activities.
ß-Arrestin Functional Assays: It helps in the activation of GPCRs and helps in the regulation of other signaling molecules such as protein kinases.
Internalization Assays: It monitors the internalization and recycling patterns of activated GPCRs.
Others: Others include reporter gene assays, trafficking Assays.

By Application

Cardiovascular System: Largest segment. The β-adrenergic receptors and angiotensin II receptors provide therapy for a wide range of cardiovascular disease, which includes coronary artery disease, hypertension, and heart failure. About 610,000 people die of heart disease in the US every year.
Oncology: GPCR controls features of tumorgenesis, that includes immune cell-mediated function, invasion, proliferation at the secondary site. In 2018, approximately 1,735,350 new cases of cancer were diagnosed in the US.
Immunology: GPCRs bind to various metabolites and transmit signals that are important for proper immune and metabolic functions.
Respiratory System: GPCRs mediates various airway smooth muscle functions that include contraction, growth, and synthetic functions that orchestrate airway inflammation and promote remodeling of the airway.
Central Nervous System: GPCRs plays a vital role in the pathophysiology of different diseases and disorders that include anxiety, depression, schizophrenia, and epilepsy.
Others: Others include metabolism and inflammation.

By Region

Americas: The largest regional market owing to the strategic investments in cancer research that would drive the growth of G protein-coupled receptors market.

Europe: Rising number of approved drugs that target GPCRs would drive the demand for G protein-coupled receptors market in this region. In November 2017, 134 GPCR targets for drugs were approved in European Union, and 128 targets were listed in the food and drug administration (FDA) orange book, thus driving the growth of G protein-coupled receptors market in this region.

Asia-Pacific: Fastest segment. Due to the presence of several emerging companies such as HD Biosciences Co. Ltd., NB Health Laboratory. An increasing number of growth initiatives taken by companies to improve their market presence will drive the growth of G protein-coupled receptor in this region.

Middle East & Africa: Increasing healthcare expenditure and rising government funding drive the demand for the G-protein coupled receptors market in this region.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/g-protein-coupled-receptors-market-8356

About US:

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Global Healthcare IoT Security Market size and forecast, 2020-2027

In traditional times patients used to book appointments with doctors for their check-ups and routine calls or used to use the medium of phones to connect with doctors limiting the point of contact and communication. But, with the introduction of the internet of things, patients and doctors were connected using the internet in the healthcare department. Now doctors can monitor their patients remotely using cameras, microphones, teleprompters, etc. Artificial intelligence with machine learning developed programs ad algorithms for healthcare departments for countries to track and record patient-doctor data which can be used globally concerning patient’s consent. With increased global access to healthcare IoT (Internet of Things), security solutions were introduced to maintain the security and decorum of the medical industry.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/946

With modernization, technology has boosted to a greater level which has led the hospitals to come to homes for tracking and maintaining patients. The introduction of insulin pumps, pacemakers, heartbeat monitors, nasal pumps, and other devices like smartphones and watches to monitor human health has made for the healthcare IoT security market. Government and private organizations play a vital role in maintaining the security of all the home hand-held devices and healthcare institutions. Healthcare IoT Security Market Research Report forecasts a CAGR of 39.5% by the year 2025 by generating a revenue of more than 100,000 Million US dollars per year.

COVID-19 Analysis:

In the November of 2019, the world woke up to an outbreak of a worldwide pandemic that affected countries economically and politically. With the immense loss of man-power countries, economical wealth came to a stand-still. Many countries like Russia, Italy, Brazil, etc. population was diminished to a considerable amount and other countries like the US, India, UK, etc. are facing a rise in active COVID-19 cases on daily basis. Global lockdowns were imposed countrywide and further state-wise to contain the spread of the virus. The Healthcare industry in coordination with the government has played a vital role in tracking and recording the patients and treating them. Healthcare IoT Security Market has shown a boost due to an increased state of emergency to isolate the patients depending on their symptoms and treating them accordingly. Sharing patient’s data is at risk and can hamper patient’s credibility thus highly secure systems were imposed to share the information across the network.

Healthcare IoT security Market Dynamics:

Drivers:

Healthcare IoT Security Market trends are on the verge of growing globally due to the increased demand for real-time data processing of patient records. More customers are inclined in booking doctor’s appointments online using hospital services that maintain a schedule between doctor and customer. This helps in the time saving of both customers and doctors by helping in removing the waiting queue. The government of all the 213 countries in the world is concerned with patient-doctor confidentiality thus has imposed HIPPA training for hospital employees to adhere to security. Nowadays our smartphones and watches are acting as health tracking data like a heartbeat monitor, blood pressure, insulin levels, oxygen levels, glucose levels, etc. which needs to be secured to avoid cybercrimes.

Challenges:

The major threats that involve the healthcare IoT security industry are easy passwords, poor authentication, loss of data while transfer due to poor network, and other cybercrimes. With an increase in the world’s population, there is an increase in patient inventory thus storing the data on-premise has become tougher with time. Thus, cloud-based storage came into the picture. On one hand, this led to easy data access and communication between doctors and patients, but on the other hand, cyber hacking and attacks on internet-connected devices became more vulnerable due to non-secure networks and failed fireball protections.

Technology Analysis:

Conventional storage systems are no prompted in healthcare systems due to the introduction of artificial intelligence (to predict the early onset of diseases by analyzing the patient’s recording using deep learning). Thus, IoT (Internet of Things) was introduced in the healthcare department where patient’s illness history, bill payments, mode of payment, name, age, date of visit, etc. were recorded and stored in hospitals inventory. This in turn is shared across platforms using network hubs making a well-connected healthcare system. To maintain cybersecurity government has imposed rules and regulations that each healthcare institution must follow while implementing IoT in the regions to maintain customer satisfaction and security. Intel recently has made a statement about IoT in healthcare security which states that healthcare IoT security market share is expected to rise by more than 2.5 Billion US dollars by the year 2025.

Segment Overview:

By Type:

Healthcare IoT Security Market is segmented as identity management, data loss prevention, access management, data encryption, threat management, system virus management, and data analysis. When a hospital or healthcare center implements IoT Security measures it must follow protocols to maintain security against threats and cybercrimes. A secured ERP system is made for entering the customer’s data with is stored in XML files secured by passwords. Virus protection software is installed to fight against unnecessary threats of computer and internet viruses while uploading and downloading documents. Firewalls are initiated to provide prevention against hacking of hardware devices associated with patient monitoring.

By Vertical:

Healthcare IoT Security Market is segmented majorly into three categories based on vertical namely: biotechnology (used to maintain the security of user data), Pharma security (used to maintain the security of pharma department against unnecessary threats towards the drug testing or discovery of new drugs or sabotaging the contents of already authorized drugs) and medical device security ( used to avoid the hacking of hardware devices associated with patient monitoring).

Regional Analysis:

Healthcare IoT security market trends show development in the private and public healthcare sector where authorities are more concerned with maintaining the industrial standards with agreeing to government regulations. North America is the top-most player when it comes to Healthcare IoT security by securing a global market share of more than 40% in regional accounting and adapting healthcare services to IoT security and privacy. Europe (Russia, Germany, etc.) has contributed about 20% to the global healthcare security market by adhering to global security standards. Asia-Pacific (China, Japan, India, Singapore) have contributed about 40% to new clinical trials of chronic diseases as read by WHO contributing to the rapid increase of the healthcare IoT security industry. Independently Asia-Pacific regions have contributed a CAGR of 47% to the healthcare industry rising the market quotient and revenue by about 2.8 million dollars in the past decade.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/healthcare-iot-security-market-946

About US:

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Tissue Microarray Market to Witness Widespread Expansion During 2020-2027

The Global Tissue Microarray Market is expected to register a CAGR of 10.54% and is anticipated to reach USD 10,914.54 million by 2023. Tissue microarrays are paraffin blocks that are created by separating cylindrical tissue cores from different paraffin donor blocks and re-embedding these into a microarray at defined array coordinates. With the help of tissue microarray, up to at least 1000 tissue samples can be arrayed into a single paraffin piece. It allows simultaneous analysis of molecules present in DNA, mRNA, and protein levels under identical, standardized conditions on a single glass slide. This adaptable strategy, in which data analysis is automated, facilitates retrospective and prospective human tissue studies.

The increasing application in drug discovery, increasing prevalence of cancer, growing advancements in biotechnology and pharmaceutical companies, and rising demand for cost-effective and accurate diagnostic methods are the major drivers propelling market growth. However, tissue microarray may not be fruitful for heterogeneous cancers, which is likely to constrain the growth of the market.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/1213

Market Dynamics

The prevalence of cancer is one of the crucial factors that drive the growth of the tissue microarray market. According to the American Cancer Society, in 2017, nearly 13% of all cancers diagnosed in adults aged 20. It further stated that rates of liver cancer, thyroid cancer, and melanoma are increasing from last few years. According to US Breast Cancer Statistics, about 1 in 8 US women (about 12%) will develop invasive breast cancer throughout their lifetime. In 2017, an estimated 252,710 new cases of invasive breast cancer were expected to be diagnosed in women in the US, along with 63,410 new cases of non-invasive (in-situ) breast cancer.

Moreover, increasing advancements in biotechnology and pharmaceutical companies and growing demand for cost-effective and accurate diagnostic methods have fueled the growth of the market. On the other hand, tissue microarray is that it may not be fruitful for heterogeneous cancers anticipated to hamper the market growth.

Segmentation

The global tissue microarray market has been divided into the procedure, technology, application, and end user. By procedure, the market has been segregated into immunohistochemistry, fluorescent in-situ hybridization, and frozen tissue array. Based on technology, the market has been segmented into DNA microarray, polymerase chain reaction (PCR), next-generation sequencing, northern blotting, and western blotting. Based on the application, the market has been bifurcated into oncology, gene expression profiling, SNP detection, double-stranded B-DNA microarrays, comparative genomic hybridization, and sequencing bioinformatics. By end-user, the market has been classified as pharmaceutical and biotechnological companies and research organization. The research organization segment accounted for a market value of USD 1876.02 million in 2016.

Key Players

The prominent players in the global tissue microarray market dynamics are Agilent Technologies, Illumina, Inc., Protein Biotechnologies Inc., Asterand Bioscience, Pantomics Inc., Applied Microarrays, Arrayit, Phalanx Biotech, QIAGEN, Takara Bio, Perkin Elmer, and Merck Sharp & Dohme Corp.

Some of the key strategies followed by the players operating in the global immunoassay in the R&D market were innovation, product development, acquisition, and expansion.

Regional Analysis

The global tissue microarray market, based on region, is divided into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The Americas is estimated to dominate the global tissue microarray market during the forecast period. This is attributed to the increase in the prevalence of cancer in the Americas, leading to the requirement for tissue microarrays. Besides, increasing application in drug discovery is also responsible for the growth of the market. Europe holds the second position in the market. Increasing emphasis on rapid diagnosis and treatment of cancer and infectious diseases, change in lifestyle, and high prevalence of cancer among geriatric population drives this market in Europe.

Additionally, the companies operating in the market are mainly focusing on mergers and acquisition, which is expected to support market growth. Asia-Pacific is expected to be the fastest-growing market for tissue microarray. Increasing prevalence of cancer, awareness among the people about their health, and changing lifestyle contribute to the growth of this market. In the Asia-Pacific region, China accounted for a market share of 21% in 2016. Furthermore, the market in the Middle East & Africa is expected to witness steady growth due to the lack of advanced medical facilities and less improvement in the healthcare domain.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/tissue-microarray-market-1213

About US:

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com